Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for oxidative stress and blood sugar control in kidney transplant patients
IRCT20160412027346N10Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of melatonin in Kidney allograft status (RTx) and type 2 diabetes mellitus (T2DM), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Oxidative stress markers and Blood sugar control. Started Jan 2025; status: completed.
02
Drugs
melatonin
03
Conditions
Kidney allograft status (RTx)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20160412027346N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160412027346N10.